Nuvoco Vistas Corporation Board Meeting Outcome

Nuvoco Vistas Corporation Earnings Call Transcript: Key Takeaways

Nuvoco delivered resilient volume growth despite severe monsoon headwinds and significant fuel cost spikes.

Nuvoco Vistas Corporation Investor Presentation: Key Takeaways

Nuvoco reports 9% YoY volume growth and 11% EBITDA growth in Q2 FY27. Strategy focuses on premiumization (45% trade mix) and capacity expansion to 35 MMTPA via Vadraj acquisition.

Nuvoco Vistas Corporation Results Update

Nuvoco Vistas reported Q2 FY27 financial results with Rs 2,790 Cr revenue and Rs 411 Cr EBITDA, while commissioning 2 MMTPA grinding capacity in Surat.

cement grinding capacity

2.0 MMTPA

Nuvoco Vistas Corporation Q2 FY27 Results: Net Profit ₹64.8 Cr, Up 78.0% YoY

Nuvoco Vistas Corporation Ltd reported revenue from operations of ₹2,790 Cr (+13.5% YoY) and net profit of ₹64.8 Cr (+78.0% YoY) for Q2 FY27.

Key figure

Net profit ₹64.8 Cr · +78.0% YoY

Nuvoco Vistas Corporation Other Announcement

Nuvoco Vistas Corporation Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting requirements.

Nuvoco Vistas Corporation Merger & Restructuring

Nuvoco Vistas' Board approved the voluntary liquidation of its wholly-owned subsidiary, Algebra Endeavour Private Limited, to simplify the Group's structure.

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.